Privia Health Group Inc (PRVA, Financial) is set to release its Q3 2024 earnings on Nov 7, 2024. The consensus estimate for Q3 2024 revenue is $714.78 million, and the earnings are expected to come in at $0.05 per share. The full year 2024's revenue is expected to be $2.88 billion and the earnings are expected to be $0.15 per share. More detailed estimate data can be found on the Forecast page.
Privia Health Group Inc (PRVA, Financial) Estimates Trends
Over the past 90 days, revenue estimates for Privia Health Group Inc (PRVA) have shown an increase from $2.86 billion to $2.88 billion for the full year 2024, while the estimates for 2025 have slightly declined from $3.22 billion to $3.22 billion. Earnings estimates have decreased from $0.18 per share to $0.15 per share for the full year 2024, and from $0.29 per share to $0.25 per share for 2025.
Privia Health Group Inc (PRVA, Financial) Reported History
In the previous quarter of June 30, 2024, Privia Health Group Inc's (PRVA) actual revenue was $728 million, which beat analysts' revenue expectations of $706.44 million by 3.05%. Privia Health Group Inc's (PRVA) actual earnings were $0.03 per share, which missed analysts' earnings expectations of $0.05 per share by -37.5%. After releasing the results, Privia Health Group Inc (PRVA) was up by 5.91% in one day.
Privia Health Group Inc (PRVA, Financial) 12 Month Price Targets
Based on the one-year price targets offered by 20 analysts, the average target price for Privia Health Group Inc (PRVA) is $25.48 with a high estimate of $37 and a low estimate of $19. The average target implies an upside of 31.93% from the current price of $19.31.
Based on GuruFocus estimates, the estimated GF Value for Privia Health Group Inc (PRVA, Financial) in one year is $57.47, suggesting an upside of 197.62% from the current price of $19.31.
Based on the consensus recommendation from 22 brokerage firms, Privia Health Group Inc's (PRVA, Financial) average brokerage recommendation is currently 1.7, indicating an "Outperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
This article, generated by GuruFocus, is designed to provide general insights and is not tailored financial advice. Our commentary is rooted in historical data and analyst projections, utilizing an impartial methodology, and is not intended to serve as specific investment guidance. It does not formulate a recommendation to purchase or divest any stock and does not consider individual investment objectives or financial circumstances. Our objective is to deliver long-term, fundamental data-driven analysis. Be aware that our analysis might not incorporate the most recent, price-sensitive company announcements or qualitative information. GuruFocus holds no position in the stocks mentioned herein.
